Dalfopristin

This classification denotes an antibiotic with the molecular formula C34H50N4O9S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R9M4FJE48E, chemically known as virginiamycin m1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26r,27s)- but generally known as dalfopristin, which bears US NIH Compound Identifier 6323289. European Medicines Agency schedules Dalfopristin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06892MIG. The term DALFOPRISTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). DALFOPRISTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dalfopristin under HS 29349990 and SITC 51579. As of Q4 2014, DALFOPRISTIN remains the US FDA Preferred Term for this commodity. Dalfopristin bears US NLM identifiers UMLS ID C0756085 and NCI Concept Code C47468. SMILES: S(=O)(=O)(C1C2N(CC1)C(=O)C1NC(OC1)CC(=O)CC(O)C=C(C=CCNC(=O)C=CC(C(OC2=O)C(C)C)C)C)CCN(CC)CC.